Estudios originales
Published on 17 de abril de 2024 | http://doi.org/10.5867/medwave.2024.03.2758
Metabolic control in type 2 diabetic patients treated with empagliflozin: A case series
Back to article
Baseline status of patients and their antidiabetic treatment.
| Arterial hypertension | 42 | 75 |
| Chronic kidney disease stage III | 9 | 16.1 |
| Metformin | 25 | 44.6 |
| Mean ± SD | Median (ICR) | |
| UAE (mg/g) | 17.6 (4.8 to 39.3) | |
| GFR (ml/min) | 89.2 ± 32.4 | |
| NPH insulin (IU) | 71.9 ± 22.5 | |
| Crystalline insulin (IU) | 30.3 ± 22.7 |
UAE, urinary albumin excretion. GFR, glomerular filtration rate. SD, standard deviation . IQR, interquartile range. IU, international units. mg/g, milligrams per gram. NPH, neutral protamine of Hagedorn.
Source: prepared by the authors of this study.